Freakanomics Podcast: How Are Psychedelics and Other Party Drugs Changing Psychiatry?

Interesting to see this very influential podcast is starting to talk about psychedelic medicine(s)

They write…

Three leading researchers from the Mount Sinai Health System discuss how ketamine, cannabis, and ecstasy are being used (or studied) to treat everything from severe depression to addiction to PTSD. We discuss the upsides, downsides, and regulatory puzzles.

Listen and subscribe to our podcast at Apple Podcasts, Stitcher, or elsewhere. Below is a transcript of the episode, edited for readability. For more information on the people and ideas in the episode, see the links at the bottom of this post.

This episode was recorded live, via Zoom, in collaboration with The Greene Space at WNYC, our hometown radio partner. We gathered three medical researchers to talk about how a variety of drugs often used for recreational purposes are increasingly being used in medical settings. It is a topic of great interest these days — one example being Michael Pollan’s best-selling book How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence. The substances we’ll be discussing today are ketamine, MDMA, and CBD. The entire Zoom conversation lasted 90 minutes; and you can watch it above. This episode was edited down to podcast length.

Read on and listen at. https://freakonomics.com/podcast/mount-sinai/

Latest posts